Pegylated Interferon (Peginterferon) Alfa-2a

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Hepatitis B, ChronicHepatitis C, Chronic

Phase 2

A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression

CompletedNCT01706575

Hoffmann-La RocheHepatitis B, Chronic

Start: 2013-01-31End: 2014-11-30Updated: 2017-02-20

Unknown Phase

An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients

TerminatedNCT02118597

Hoffmann-La RocheHepatitis C, Chronic

Start: 2014-05-31End: 2015-05-31Updated: 2016-12-12

Related Papers

Add‐on peginterferon alfa‐2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen‐negative chronic hepatitis B genotype D

Journal of Viral Hepatitis2018-09-0623 citations